HAB-439

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameHAB-439
Drug Alias NameHAB-439
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAminopeptidase inhibitors
TargetsAminopeptidase
Therapy Area/IndicationsImmunologic Deficiency Syndromes
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHoechst AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHoechst AG
Active IndicationsN/A
Inactive IndicationsImmunologic Deficiency Syndromes

Other Information

ATC CodeN/A
Related LinksN/A